Institutional investors control 5.87% of the outstanding shares in ROSG. This represents a greater percentage of ownership than at almost any other company in the Biotechnology industry. Additionally, during the quarter ended September 2016, these large investors purchased a net $29.1 thousand shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
MORGAN STANLEY & CO. LLC Bought 24.4 Thousand shares of Rosetta Genomics Ltd